CTLA4 and melanoma: (2) Checkpoint inhibitors: Immunotherapy for melanoma has introduced the use of checkpoint inhibitors, which are drugs that block proteins like PD-1 and CTLA-4 to prevent cancer cells from evading immune system detection.